| Literature DB >> 23795239 |
Jo-Anne Pinson1, Zhaohua Zheng, Michelle S Miller, David K Chalmers, Ian G Jennings, Philip E Thompson.
Abstract
A series of aminoacyl-triazine derivatives based upon the pan-PI3K inhibitor ZSTK474 were identified as potent and isoform selective inhibitors of PI3Kβ. The compounds showed selectivity based upon stereochemistry with L-amino acyl derivatives preferring PI3Kβ while their D-congeners favoured PI3Kδ. The mechanistic basis of this inhibition was studied using site-directed mutants. One Asp residue, D862 was identified as a critical participant in binding to the PI3Kβ-selective inhibitors distinguishing this class from other reported PI3Kβ-selective inhibitors. The compounds show strong inhibition of cellular Akt phosphorylation and growth of PTEN-deficient MD-MBA-468 cells.Entities:
Keywords: PI3 kinase; ZSTK474; cancer; p110β
Year: 2013 PMID: 23795239 PMCID: PMC3688631 DOI: 10.1021/ml300336j
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345